A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on the state of ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...

Eran Harary, Senior Vice President of Global Early Clinical Development at Teva, said: “This collaboration will provide ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles ...

Our luminaries look across the pharmaverse with conclusions and curiosity ...

Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as Chief Scientific Officer (CSO). Mikkel is a ...

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...